Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/14960257

Download in:

View as

General Info

PMID
14960257